Medtronic Puts Spine Business Under Close Evaluation
This article was originally published in The Gray Sheet
Executive Summary
Medtronic may need to reassess the "strategy and approach” for its spine business if performance doesn't improve, CEO Omar Ishrak said last week. Ishrak did not take a divestiture off the table, but put more emphasis on the potential for internal restructuring.